RecruitingNot Applicable

Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies

Canada1,596 participantsStarted 2023-08-01

Plain-language summary

This is a pragmatic, double-blind, randomized, controlled trial, to evaluate the effect of implementing a Computer-assisted detection (CADe) system within the routine clinical practice of Canadian healthcare institutions. The main hypothesis of this study is that the ADR in the operating room equipped with the GI genius CADe system will be significantly higher than the ADR in the ordinary operating room.

Who can participate

Age range45 Years – 89 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * indication of undergoing a screening, surveillance, or diagnostic colonoscopy * Age 45-89 years Exclusion Criteria: * Patients undergoing emergency colonoscopy * Patients with a known familial polyposis syndrome or a known inflammatory bowel disease

What they're measuring

ADR

Timeframe: 30 days

Trial details

NCT IDNCT05244278

SponsorCentre hospitalier de l'Université de Montréal (CHUM)

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-08-01

View on ClinicalTrials.gov More Artificial Intelligence trials